Risorse esterne
Opinione della community
Prezzo Variazione Volume
1.28 0 €
P/E Obiettivo ad 1anno
0 7.85 €

Compra - Vendi

Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Altri utenti che hanno investito

Transations in last week
Buy: 116
Sell : 46

Salvatore Gagliotta Filippo Galmarini jonathan_summer Marco^3 Simone Bonzanini F9 GOLIATH81 Boaguze Machenesaccio matthi berchtold Francesco De Stefano



Can Acasti Pharma Inc. (NASDAQ:ACST) Grab Upward Traction? - FLBC News

Bargain stock hunters have honed in their attention of late on shares of Acasti Pharma Inc. (NASDAQ:ACST). The stock is currently valued at $1.31 after moving -0.76% in the most recent session and 1.59% over the past 5 trading days. Given that the ...altro » Leggi

Technicals in Focus For Acasti Pharma Inc (ACST) - Providence Standard

Tracking stock levels, Acasti Pharma Inc (ACST) has a 14-day Commodity Channel Index (CCI) of 111.16. Even though the ... Wilder introduced RSI in his book “New Concepts in Technical Trading Systems” which was published in 1978. RSI measures the ...altro » Leggi

EPS for WesBanco (WSBC) Expected At $0.62, Shorts at Acasti ... -

The stock decreased 1.08% or $0.44 during the last trading session, reaching $40.23. About shares traded. WesBanco Inc (NASDAQ:WSBC) has risen 18.72% since July 11, 2016 and is uptrending. It has outperformed by 2.02% the S&P500. Acasti Pharma ...altro » Leggi

Acasti Pharma Inc. (ACST) stock price close at $1.33 - WsNews 4investors

Acasti Pharma Inc. (ACST) stock price tumbled -0.67% to finalize at $1.33 throughout previous buying and selling session. A total of 0 million shares exchanged at hands and its average trading volume is standing at 0.03 million shares. Shares of Acasti ...altro » Leggi

Breakout Session Alert as Shares Pop BMO: Acasti Pharma Inc ... - Aiken Advocate

Will shares of Acasti Pharma Inc. (NASDAQ:ACST) hold onto their early gains? The stock is gapping up 3.13% before market open touching $1.32 on a recent bid. As we move into the second half of the year, investors will be keeping a close watch on their ... Leggi

Money Making Stocks: Reed's, Inc. (NYSE:REED), Acasti Pharma ... - Benchmark Monitor

Reed's, Inc. (NYSE:REED)'s stock on Monday traded at beginning with a price of $1.65 and when day-trade ended the stock finally declined -3.03% to reach at $1.60. Analyst's mean target price for REED is $5.50 while analysts mean recommendation is ...altro » Leggi

1.60 - MarketWatch

Acasti Pharma, Inc. engages in the research, development, and commercialization of krill oil-based forms of omega-3 phospholipid therapies. It seeks to treat certain cardiometabolic disorders such as abnormalities in blood lipids, also known as ... Leggi

Acasti Pharma Grants Stock Options - Benzinga

LAVAL, QUEBEC--(Marketwired - Jun 14, 2017) - Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST)(TSX:ACST), today announced the grant of an aggregate of 1,021,500 stock options to its employees, executives and members of the Board of ...altro » Leggi

$0.67 EPS Expected for Neptune Technologies & Bioressources ... -

The Company's products include Krill-Based Nutraceutical Products, including Neptune Krill Oil , OCEANO3, Formulations Derived from NKO and Neptune Krill Aquatein (NKA); Other Nutraceutical Products, and Pharmaceutical Product Candidate (CaPre)-Acasti ...altro » Leggi

Acasti Pharma Share Gains Massive in Percentage Terms, Tiny in ... - 24/7 Wall St.

It is not that often that you see biotech or biohealth stocks moving north of 50% in one trading session. If you do it is usually due to merger news or a rumor about a merger. In the case of Acasti Pharma Inc. (NASDAQ: ACST), the company's shares were ... Leggi